SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
FibroBiologics appointed Kathleen Rubins, Ph.D., a retired NASA astronaut and microbiologist, as a Class III director effective July 8, 2026, with assignment to the Audit, Compensation, and Governance committees. Dr. Rubins brings distinguished scientific credentials and has served on the company's Scientific Advisory Board since 2022.
View raw filing on EDGAR →The Fourth Amendment modifies an existing Revolving Credit Facility by extending the revolving period to July 2, 2028 and stated maturity to July 2, 2030, reducing interest rates (from SOFR+2.35% to SOFR+1.95% during revolving period), and adjusting financial covenants and concentration limits. While this is technically an amendment to existing debt rather than a new issuance, it materially restructures the Company's direct financial obligations and credit terms, which is reportable under Item 1.01 as a material definitive agreement. The extension of maturity dates and reduction in borrowing costs are material to investors assessing the registrant's capital structure and financial flexibility.
View raw filing on EDGAR →Paul Grewal's departure as Chief Legal Officer and Secretary effective July 31, 2026 is the principal disclosed action. While the filing also mentions Molly Abraham's appointment as General Counsel and an advisor agreement with severance-like terms, the core event centers on Grewal stepping down from a senior officer role. This is material to investors as it affects the registrant's leadership and legal function.
View raw filing on EDGAR →IKS Health completed its acquisition of TruBridge, Inc., with TruBridge now operating as a wholly owned subsidiary. All shares of Company Common Stock were cancelled and converted into merger consideration, and TruBridge's Common Stock ceased trading on NASDAQ on July 9, 2026.
View raw filing on EDGAR →The filing discloses the termination of Robert J. Willette as Chief Executive Officer effective April 20, 2026, with a Separation Agreement finalized July 8, 2026. While the disclosure includes compensatory details (cash payment of $1,800,000 and 300,000 stock options), the principal event is the departure of the CEO. The termination was without cause and involved no disagreement with the Company, and the filing centers on the departure itself rather than on compensation arrangement modifications.
View raw filing on EDGAR →Paycom appointed two directors to its board effective July 8, 2026: Craig E. Boelte, former CFO (retired February 2025), and William Kerber, former CIO (departed 2017). Both individuals bring substantial company history and expertise to the board.
View raw filing on EDGAR →Whitestone REIT shareholders voted on and approved an all-cash acquisition by Ares Real Estate funds at $19.00 per share (approximately $1.7 billion transaction) at a special meeting held on July 9, 2026. The merger proposal received 37,039,161 votes in favor versus 116,016 against and 86,516 abstentions; an advisory say-on-pay proposal failed to achieve majority support. The transaction is expected to close on July 14, 2026.
View raw filing on EDGAR →Morgan Stanley Direct Lending Fund entered into a Fourth Supplemental Indenture on July 9, 2026, to issue $350.0 million aggregate principal amount of 6.100% notes due 2031, with net proceeds of approximately $341.6 million used to repay existing secured indebtedness.
View raw filing on EDGAR →Blue Owl Technology Income Corp. voluntarily reduced its aggregate committed debt capacity from an undisclosed prior level to $3.5 billion across multiple SPV asset facilities and other credit arrangements on July 2, 2026, in order to reduce borrowing costs and align with target leverage. While this is a financial event involving debt facilities, it does not fit the specific categories of debt_issuance (creation of new obligations), covenant_breach (violation of existing terms), or dividend_distribution. The reduction is a strategic capital structure adjustment that affects the company's financial flexibility and leverage profile, making it material to investors assessing the registrant's financial position and strategy.
View raw filing on EDGAR →The filing discloses the declaration and payment of a quarterly dividend on the Company's 9.50% Series A Cumulative Redeemable Preferred Stock, with a dividend of $0.73889 per share payable on July 31, 2026. This is a routine but material dividend distribution to preferred shareholders, authorized by the Board of Directors and disclosed under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →The disclosure centers on compensatory arrangements approved by the Human Capital and Compensation Committee for Laura Cockrill following her appointment as CFO. The material elements are: base salary increase to $650,000, Annual Bonus Plan target increase to 175% of base salary, LTI target increase to 300% of base salary, and a $1,000,000 retention bonus paid in three tranches through 2029. While the section mentions her prior appointment as CFO (which occurred June 22, 2026 and was previously reported), the substantive new disclosure here is the compensation adjustment and retention bonus arrangement, making this an exec_compensation event.
View raw filing on EDGAR →Interactive Strength Inc. entered into a definitive Stock Purchase Agreement on July 7, 2026 to acquire 100% of STEPR, Inc., a connected stair-climbing fitness equipment company, for total consideration of approximately $19 million in cash, debt, and contingent equity. The transaction is expected to close in Q4 2026 and advances the Company's multi-brand fitness platform strategy, with pro forma revenue guidance exceeding $50 million.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Netskope's 2026 annual meeting held on July 7, 2026. The filing reports voting outcomes on two proposals: (1) election of Class I directors Sanjay Beri and Arif Janmohamed, and (2) ratification of KPMG LLP as independent auditor. The detailed vote tallies (votes for, against, withheld, and broker non-votes) are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors assessing board composition and audit oversight.
View raw filing on EDGAR →This announcement discloses a Share Purchase Plan (SPP) — an equity offering to shareholders — with an updated timetable following ASX waiver approvals. SPPs are a form of direct equity issuance that dilutes existing shareholders. The announcement confirms the Company has received waivers from ASX Listing Rules 7.1 and 10.11 and provides revised closing and allotment dates, indicating a material capital-raising activity that would affect investor assessment of share dilution and capital structure.
View raw filing on EDGAR →The filing discloses that ENDRA regained compliance with Nasdaq's Minimum Stockholders' Equity Requirement (Nasdaq Listing Rule 5550(b)(1)) after initially falling below the $2,500,000 threshold. However, the company is now subject to a one-year Discretionary Panel Monitor period, during which any future non-compliance with Nasdaq Listing Rules will result in immediate delisting without opportunity for a cure period or compliance plan. This represents a material delisting risk that would significantly affect investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →The filing discloses the dismissal of Fortune CPA Inc. as the Company's independent registered public accounting firm effective July 6, 2026, and the simultaneous appointment of Wei, Wei & Co., LLP as the successor auditor. While both a departure and appointment occurred, the central event is the auditor change itself. The disclosure notes a material weakness in internal control over financial reporting relating to insufficient staff with appropriate GAAP and SEC reporting knowledge, which contextualizes the change. This is a classic Item 4.01 auditor change disclosure and is material to investors assessing the registrant's financial reporting quality and governance.
View raw filing on EDGAR →The press release announces the appointment of Ralph (Cody) Kittle to Telesat's Board of Directors as a nominee of MHR Fund Management LLC, succeeding Michael Targoff. This is a discrete governance event involving the appointment of a director to the board. While the release also acknowledges Targoff's departure after 19 years, the principal disclosed action is Kittle's appointment to the board, making this an exec_appointment event. Board composition changes at public companies are material to investors assessing governance and oversight.
View raw filing on EDGAR →Blue Gold has disclosed that it is at risk of delisting from Nasdaq due to failure to meet continued listing requirements, specifically shareholders' equity requirements. The company has undertaken remedial initiatives including balance sheet optimization, shareholder authorization for a reverse split, and potential transfer to Nasdaq Capital Market.
View raw filing on EDGAR →Blue Gold settled US$3.6 million in accounts payable owed by its Ghanaian subsidiary to FGR through conversion into 3,617 shares of Series A Perpetual Convertible Preferred Stock, subject to a 19.99% Nasdaq conversion cap. This material debt-to-equity conversion and liability settlement represents a significant capital restructuring and release of contingent liabilities related to the Bogoso-Prestea mine acquisition.
View raw filing on EDGAR →The press release announces an interim cash dividend of USD 1.50 per ordinary share with specific payment dates (July 27, 2026 for NASDAQ shareholders, July 20, 2026 for JSE shareholders). The disclosure includes ex-dividend dates, record dates, and detailed tax and currency conversion information for South African resident shareholders, which are hallmarks of a dividend distribution announcement.
View raw filing on EDGAR →Ambipar executed a Restructuring Support Agreement with creditors holding a majority stake of Green Notes and an Amended and Restated Loan Agreement with Itaú BBA, representing material debt restructuring transactions that significantly alter the registrant's capital structure and financial obligations.
View raw filing on EDGAR →Ambipar disclosed a comprehensive business update and financial condition assessment following its September 2025 pre-injunction filing in Brazil and October 2025 Chapter 11 filing in the U.S., detailing material operational impacts including approximately BRL 800 million backlog reduction, contract cancellations, client attrition, and expected revenue contraction for 2026.
View raw filing on EDGAR →The Company amended a securities purchase agreement and convertible promissory note with Welle Environmental, revising anti-dilution provisions to establish a US$1.30 per-share floor price for equity and convertible securities issuances, with limited exceptions. This amendment reflects negotiation of dilution protections for the investor and indicates an underlying dilutive equity or convertible issuance transaction that materially affects shareholder interests.
View raw filing on EDGAR →byNordic Acquisition Corp disclosed the extension of its business combination deadline from July 12, 2026 to August 12, 2026 by depositing $17,470 into its trust account. This is a material operational event for a SPAC, as the extension directly affects the company's timeline to complete its stated business purpose and impacts the registrant's continued existence as a going concern if no business combination is completed by the extended deadline. While not a specific named event type, this is clearly an operational/strategic matter affecting the SPAC's core mission.
View raw filing on EDGAR →This disclosure describes entry into a Merger Agreement between two wholly owned subsidiaries of PMGC Holdings Inc. (AGA Precision Systems LLC merging into A&B Aerospace, Inc.), which constitutes a material acquisition or change of control event under Item 1.01. Although the merger involves only internal subsidiaries, the formalization of the merger agreement and its anticipated consummation represent a material corporate restructuring that would affect investor assessment of the company's organizational structure and operations.
View raw filing on EDGAR →T3 Defense acquired 60% of Project 35, an Israeli defense technology company, in exchange for 21,059,871 shares of common stock and a $1,250,000 promissory note, with an additional $2,500,000 investment obligation. This is a material acquisition disclosed under Item 2.01, involving significant equity dilution and cash commitment for a strategic defense-sector asset with established customer relationships and proprietary technology (HY-380 autonomous interceptor).
View raw filing on EDGAR →The disclosure centers on the appointment of Derek Rush as a director and member of the audit committee on July 2, 2026, increasing the Board to seven members. While the section also mentions an indemnification agreement, the principal disclosed action is the appointment of a person to a board role. This is material to investors as it affects board composition and governance structure.
View raw filing on EDGAR →The disclosure describes a clinical trial milestone—preparation of a statistical analysis plan (SAP) for an interim analysis of a Phase 2/3 randomized, placebo-controlled trial of tafenoquine in severe babesiosis, with 23 of 33 planned patients enrolled as of the filing date. This is a material operational and regulatory development for a clinical-stage biopharmaceutical company, as it outlines the pathway toward potential FDA submission and a Commissioner's National Priority Review Voucher application by Q1 2028. The event is clearly operational/strategic (clinical development progress) rather than financial, governance, legal, or existential in nature, and does not fit a more specific category.
View raw filing on EDGAR →Freedom Metals Acquisition Corp. consummated its initial public offering on July 9, 2026, issuing 27,500,000 units at $10.00 per unit for gross proceeds of $275 million, together with a concurrent private placement of 825,000 units to the Sponsor, Cohen, and CS at the same price for $8.25 million in gross proceeds.
View raw filing on EDGAR →On July 7, 2026, Bronwyn Barnes, Quinton Hennigh, Hugh Callaghan, and Michael Porter were appointed to the board of directors, with Barnes serving as Chairwoman and Porter chairing both the Audit and Compensation Committees.
View raw filing on EDGAR →The 6-K discloses the appointment of two new independent directors effective July 9, 2026: Mr. King Fui Lee as an independent director and Audit Committee Chairman, and Mr. Ke Zhang as an independent director. While the filing also mentions the departure of two prior independent directors (Ms. Jie Jiao and Mr. Jingchuan Li), the principal disclosed action is the appointment of new board members with detailed biographical information, making this an exec_appointment event. Board composition changes affecting audit oversight are material to investors.
View raw filing on EDGAR →CleanCore entered into a Contribution Agreement, LLC Agreement, and Master Platform Agreement on July 2, 2026, to form and capitalize a joint venture with HST Technologies for developing and operating data center facilities, with CleanCore contributing up to $100 million for a 99% capital interest and aggregate capital commitments contemplated up to $2 billion. The company announced the closing of its first data center project in partnership with HST Technologies, committing to fund an initial 200-megawatt West Texas data center campus with $100 million expected by Q1 2027, with potential expansion to 500+ megawatts by 2030, representing a material entry into the AI infrastructure business.
View raw filing on EDGAR →Osprey Acquisition Corp. III consummated an initial public offering of 30,015,000 units at $10.00 per unit on July 2, 2026, generating $300,150,000 in gross proceeds, plus a simultaneous private placement of 747,000 units for $7,470,000. This is a material capital-raising event involving the issuance of equity securities (Class A ordinary shares and warrants) to public and private investors. While this is technically a SPAC IPO rather than a traditional dilutive issuance to existing shareholders, the event represents a substantial unregistered or newly-registered equity issuance that materially affects the company's capitalization and is reportable under Item 8.01.
View raw filing on EDGAR →This press release announces the pricing of a public offering of 8,000,000 units at $0.79 per unit, generating approximately $6.32 million in gross proceeds. Each unit comprises one Class A ordinary share and one warrant, representing a dilutive equity issuance. The offering is registered on Form F-1 and is material to investors as it significantly increases share count and dilutes existing shareholders.
View raw filing on EDGAR →The 6-K discloses the results of an Adjourned Annual General Meeting of Shareholders held on July 9, 2026, in which all fourteen proposals were approved by the required majority. This is a direct disclosure of shareholder vote results, matching the definition of Item 5.07 (shareholder_vote_results). The approval of multiple proposals at an annual meeting, including governance and potentially compensation matters, is material to investors' understanding of the company's governance and strategic direction.
View raw filing on EDGAR →The 6-K discloses that on June 29, 2026, Nasdaq halted trading in the Company's Class A ordinary shares pending satisfaction of Nasdaq's request for additional information, with trading to remain halted until the Company fully complies. This constitutes a material delisting risk under Item 3.01 equivalent, as the trading halt is a precursor to potential delisting and directly threatens the Company's continued listing status on Nasdaq.
View raw filing on EDGAR →Air Industries Group entered into an Amended and Restated Agreement and Plan of Merger with Tenax Aerospace Acquisition, LLC on July 2, 2026, superseding the original merger agreement from February 16, 2026. The transaction involves issuance of 126.9 million shares of AIR common stock (25.38 million post-reverse split) to Tenax members, resulting in Tenax members owning approximately 96% of the combined company post-closing, constituting a material change of control requiring stockholder approval and SEC registration on Form S-4.
View raw filing on EDGAR →Hongli Group received a Nasdaq deficiency notice on July 2, 2026, for failure to maintain the minimum bid price of $1.00 per share required under Nasdaq Listing Rule 5550(a)(2). The Company has 180 calendar days (until December 29, 2026) to regain compliance or face potential delisting. The press release explicitly states that if the Company does not cure the deficiency and does not meet eligibility criteria for an extension, "Nasdaq will provide notice that its securities will be subject to delisting." This is a material disclosure of delisting risk under Item 3.01 equivalent.
View raw filing on EDGAR →Fermi Inc. commenced an offering of $350 million aggregate principal amount of convertible senior notes due 2031, with an additional $52.5 million option for initial purchasers. Net proceeds are intended for capped call transactions and general corporate purposes.
View raw filing on EDGAR →This disclosure announces an estimated redemption price ($10.6973 per share) in connection with a shareholder meeting scheduled for July 10, 2026, where shareholders will vote on an Extension Amendment Proposal to extend the business combination deadline from July 16, 2026 to January 16, 2027, with optional monthly extensions. While the filing involves shareholder voting and governance matters, it does not fit the specific `shareholder_vote_results` category (which applies to results *after* a vote), nor does it fit other named governance types. The announcement of the redemption price and extension terms is a material governance event affecting shareholder rights and the company's timeline, making `governance_other` the most appropriate classification.
View raw filing on EDGAR →The filing discloses a virtual investor conversation regarding the proposed business combination between Constellation Acquisition Corp I (CSTA), HiTech Minerals Inc., and US Elemental Inc. (PubCo), with anticipated Nasdaq listing. Although Item 7.01 is technically a Regulation FD disclosure of the event invitation itself, the substance centers on a material M&A transaction—the business combination and resulting public listing—which is the core event being communicated to investors. The filing explicitly references the "proposed business combination" multiple times and discusses the anticipated listing of PubCo on Nasdaq, making this a material acquisition/change-of-control event.
View raw filing on EDGAR →Eureka Acquisition Corp issued an unsecured promissory note (Extension Note) in the principal amount of $8,253.03 to Marine Thinking Inc. on July 7, 2026, creating a direct financial obligation with standard default provisions and a conversion feature into private units.
View raw filing on EDGAR →Eureka Acquisition Corp disclosed a proposed business combination with Marine Thinking, including registration rights and transfer restrictions for units issuable upon conversion of the Extension Note, with a Form S-4 registration statement filed in connection with the transaction.
View raw filing on EDGAR →BSTR Newco entered into a loan agreement on March 15, 2026 for $2.5 million, subsequently amended on June 2, 2026 and July 8, 2026 to increase the principal sum to $4.6 million total. The loan carries an interest rate of SOFR + 3.90% and is material to the registrant's financing for operating costs and transaction expenses related to a pending business combination.
View raw filing on EDGAR →Biodexa Pharmaceuticals PLC is holding an Extraordinary General Meeting on July 29, 2026, to approve four material resolutions: (1) a 10,000-to-1 share consolidation with creation of deferred shares; (2) authorization to allot up to £25,000,000 in equity securities; (3) disapplication of pre-emption rights for cash issuances; and (4) adoption of new articles of association. These structural and constitutional changes materially affect the company's capital structure and future financing flexibility.
View raw filing on EDGAR →This is a news release dated July 9, 2026 disclosing Orla Mining's second quarter 2026 operating results, including gold production figures (88,265 ounces in Q2, 169,471 ounces YTD), operational metrics for Musselwhite and Camino Rojo mines, liquidity position ($451.0 million cash, $318.7 million net cash), and reaffirmation of 2026 production guidance (340,000–360,000 ounces). The release explicitly states "Orla expects to release its second quarter 2026 operating and financial results on Tuesday, August 4, 2026," confirming this is an operational and financial results announcement. Material to investors assessing operational performance and cash generation.
View raw filing on EDGAR →Daniel André Stieler resigned as Chairman of the Board of Directors and board member of Vale S.A. effective July 6, 2026. The 6-K furnishes Vale's official response to a Brazilian securities regulator (CVM) inquiry regarding media reports of his resignation and associated compensation arrangements. The departure of a board chairman is a material governance event affecting investor assessment of the company's leadership and control structure.
View raw filing on EDGAR →This is a press release announcing Sigma Lithium's second-quarter 2026 operational and production results. The company reports producing 35,000 tonnes of lithium oxide concentrate in 2Q26, exceeding guidance of 33,000 tonnes by 6%, and provides forward-looking production volumes and cash-flow forecasts for Phases 1, 2, and 3. The release explicitly states "Sigma Lithium expects to release its full second quarter 2026 financial and operating results on August 14, 2026," confirming this is an interim operational disclosure ahead of full financial results. The disclosure of production metrics, operational efficiency improvements, and forward guidance materially affects investor assessment of the company's execution and growth trajectory.
View raw filing on EDGAR →Petrobras announces completion of acquisition of exploration block in São Tomé and Príncipe, Africa, with Petrobras taking 75% operatorship interest. This is a material acquisition of an oil and gas exploration asset aligned with the company's reserve-replenishment strategy, representing entry into a new geographic frontier and portfolio diversification.
View raw filing on EDGAR →Christopher M. Smith, a board member of Pacific Biosciences, resigned from the Board effective immediately on July 8, 2026. The disclosure centers on the departure itself, with explicit confirmation that no disagreement with the Company prompted the resignation. This is a straightforward director departure under Item 5.02, material to investors as board composition affects governance and oversight.
View raw filing on EDGAR →